BERLANDES Unveils Innovative Ovarian Capsules

BERLANDES, a company specializing in biotechnology and cell regeneration, unveils its latest product: PCCIDINCT2™ Ovarian Capsules. These capsules aim to support ovarian health and treat female reproductive problems. The product is based on decades of research in collaboration with prestigious institutions such as the Royal Academy of Sciences.

The PCCIDINCT2™ formula, developed under the direction of Stephen John Williams BUSBY, incorporates effective antioxidants to cleanse ovarian cells and compounds such as inositol and vitamin B9 to balance hormones. A mint extract helps improve emotional well-being.

The capsules target a variety of symptoms, from irregular menstrual cycles to menopausal symptoms, promising to improve women's health. BERLANDES continues to affirm its mission to improve women's health worldwide.